Active Ingredient(s): Lodoxamide
FDA Approved: * September 23, 1993
Pharm Company: * ALCON
Category: Allergies, Cough & Cold

Lodoxamide is an antiallergic pharmaceutical drug. It is marketed under the tradename Alomide in the UK. Like cromoglicic acid it acts as a mast cell stabilizer.[1] In 2014 lodoxamide and bufrolin were found to be potent agonists at the G protein-coupled receptor 35, an orphan receptor believed to play a role in inflammatory processes, pain and the development of stomach cancer.[2] See also Nedocromil Zaprinast Amlexanox Pemirolast Pamoic acid Kynurenic acid... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Alomide 1.78 mg/ml Ophthalmic Solution/ Drops
NDC: 0065-0345
Alcon Laboratories, Inc.
Alomide 1 mg/ml Ophthalmic Solution/ Drops
NDC: 0078-0736
Novartis Pharmaceuticals Corporation